Jazz Pharmaceuticals (JAZZ) has had a rough couple of weeks. The drugmaker closed at $218.42 on Friday, Oct. 9, down about 11% over the...
Global trade, energy transition, financial regulation, multinational corporations, and macroeconomic trends.
Categories
Recent Posts
- Intel stock surges as JPMorgan upgrades shares after 14% weekly plunge
- Hundreds rush for AI jobs at ‘data led’ UK financial regulator
- Meta Muse AI agent shares man’s home address with Facebook Marketplace buyer
- KFC plans a massive soda change last seen 40 years ago
- Iran’s main oil terminals remain empty as US blockade bites